Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases

被引：0
作者：
Jui-Ming Liu
Cheng-Ping Yu
Heng-Chang Chuang
Chun-Te Wu
Ren-Jun Hsu
机构：
[1] Ministry of Health and Welfare,Division of Urology, Department of Surgery, Taoyuan General Hospital
[2] National Yang-Ming University,Faculty of Medicine
[3] National Defense Medical Center,Graduate Institute of Life Sciences
[4] National Defense Medical Center,Department of Pathology and Graduate Institute of Pathology and Parasitology, Tri
[5] Chang Gung Memorial Hospital,Service General Hospital
[6] Tzu Chi University,Department of Urology
来源：
Prostate Cancer and Prostatic Diseases | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：475 / 482
页数：7
相关论文
共 50 条
  • [21] Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis
    Shahani, Sadeka
    Braga-Basaria, Milena
    Basaria, Shehzad
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (06) : 2042 - 2049
  • [22] Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer
    Khosrow-Khavar, Farzin
    Rej, Soham
    Yin, Hui
    Aprikian, Armen
    Azoulay, Laurent
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (02) : 201 - +
  • [23] Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer
    Jonathan Assayag
    Hui Yin
    Serge Benayoun
    Michael N. Pollak
    Samy Suissa
    Laurent Azoulay
    Cancer Causes & Control, 2013, 24 : 839 - 845
  • [24] Androgen Deprivation Therapy and the Risk of Colorectal Cancer in Prostate Cancer Patients
    Assayag, Jonathan
    Yin, Hui
    Suissa, Samy
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 346 - 346
  • [25] Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer
    Assayag, Jonathan
    Yin, Hui
    Benayoun, Serge
    Pollak, Michael N.
    Suissa, Samy
    Azoulay, Laurent
    CANCER CAUSES & CONTROL, 2013, 24 (05) : 839 - 845
  • [26] Androgen deprivation therapy for prostate cancer
    Das, Manjulika
    LANCET ONCOLOGY, 2017, 18 (10) : E567 - E567
  • [27] Androgen Deprivation Therapy in High-Risk Prostate Cancer
    Buyyounouski, Mark K.
    ONCOLOGY-NEW YORK, 2010, 24 (09): : 806 - 809
  • [28] Cardiovascular risk during androgen deprivation therapy for prostate cancer
    Jones, Thomas Hugh
    BRITISH MEDICAL JOURNAL, 2011, 342
  • [29] Androgen deprivation therapy for prostate cancer
    Singer, Eric A.
    Golijanin, Dragan J.
    Miyamoto, Hiroshi
    Messing, Edward M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (02) : 211 - 228
  • [30] Androgen deprivation therapy and the incidence of autoimmune diseases.
    Klil-Drori, Adi Joseph
    Tascilar, Koray
    Yin, Hui
    Aprikian, Armen G.
    Azoulay, Laurent
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345